Drug Policy as an Integral Part of State Health Policy - International Examples

• Autorzy: Anna Różalska , Marcin Czech
• Języki publikacji: EN

Abstrakty

EN

Medicines policy plays a major role in protecting, maintaining and restoring people's health and is an integral part of state health policy. It embraces brand and generic drugs, biologics, vaccines and natural health products. Drug policy ensures an access to safe and effective medicines while reducing patient participation in treatment costs. Medicine policy includes among others, patent law, licensing, prescribing, pricing, reimbursement, formulary management, eligibility, pharmacy, funding of research in the life sciences services[1] The national pharmaceuticals policy is the one based on drug use where patients receive medications according to their clinical needs, in the individual required doses, in the right time, at the lowest possible cost [3]. In this article national medicine policies in Australia, United Kingdom, Sri Lanka, South Africa and Poland were presented from the viewpoints of drugs' spending, regulations and practice. The general policy framework addresses the inherent tensions within the objectives of attaining affordable access to medicines, while maintaining a viable pharmaceutical industry, and achieving quality medicines and healthcare systems. In Poland development of medicine policy is under creation.(original abstract)

Słowa kluczowe

EN

Combating drug addiction; Health care policy

PL

Zwalczanie narkomanii; Polityka zdrowotna

• Czasopismo: Journal of Health Policy and Outcomes Research
• Rocznik: 2017
• Numer: nr 1
• Strony: 4--13

Twórcy

autor

Anna Różalska

• Institute of Mother and Child, Warsaw University of Technology Business School, Poland

autor

Marcin Czech

• Warsaw University of Technology Business School, Poland

Bibliografia

• Kanji N, Hardon A, Harnmeijer JW, Mamdani M, Walt G: Drugs Policy in Developing Countries. 1992, London: Zed Books, 136
• Another Development in Pharmaceuticals. Development Dialogue, Volume 2. 1985, Uppsala: Dag Hammarskjold Foundation, http://www.dhf.uu.se/ publications/development-dialogue/another-development-in-pharmaceuticals/_16/08/2017
• https://en.wikipedia.org/wiki/Pharmaceutical_policy_16/08/2017
• WHO: Equitable access to essential medicines: a framework for collective action. 2004, Geneva: World Health Organization,
• Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R: Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 2009, 373 (9659): 240-9. 10
• Dukes MNG HRFM, de Joncheere CP, Rietveld AH: Prices, affordability and cost containment. 2003, Geneva: Drugs and Money, World Health Organization; 2003, 7
• United Nations: Delivering on the Global Partnership for Achieving the Millennium Development Goals, in MDG Gap Task Force Report. 2008, New York: United Nations
• Calabrese LH: Changing patterns of morbidity and mortality in HIV disease. Cleveland Clinical Journal of Medicine. 2001, 68 (2): 109-110
• WHO: How to develop and implement a national drug policy, in WHO Policy Perspectives on Medicines. 2003, Geneva: World Health Organization, Available at: http://apps.who.int/medicinedocs/en/d/ Js4869e/ 18/08/2017
• WHO: Guidelines for developing national drug policies. 1988, Geneva: World Health Organization, available at: http://whqlibdoc.who.int/publications/1988/9241542306_eng.pdf 18/08/2017
• The Global Use of Medicines: Outlook through 2017. Report by the IMS Institute for Healthcare Informatics
• Journal of Pharmaceutical Policy and Practice20136:5. "National medicines policies - a review of the evolution and development processes"
• https://en.wikipedia.org/wiki/Essential_medicines_ policies 14/.08/.2017
• . http://www.health.gov.au/nationalmedicinespolicy 15.08.2017 Am I entitled to NHS treatment when I visit England?". www.nhs.uk. 21/08/2017 [14]
• http://www.hta.nhsweb.nhs.uk 27/08/2017
• WHO: How to develop and implement a national drug policy, in WHO Policy Perspectives on Medicines. 2003, Geneva: World Health Organization
• blog.dzp.pl/ rynekaptek.pl 27/08/2017
• https://www.infarma.pl/biuro-prasowe/aktualnosci-i-wydarzenia/konferencja- pulsu-medycyny -i- pulsu-farmacji -na-temat-polityki-lekowej-panstwa/ 26/07/2017
• http://www.rynekzdrowia.pl/Farmacja/Liczymy-na-kontynuacje-dialogu-dotyczacego-regulacji-w-polityce-lekowej,168800,6.html 24/08/2017
• http://www.health.gov.au 26/08/2017
• WHO: Country pharmaceutical situations; Fact Book on WHO Level 1 indicators 2007. 2009, Geneva: World Health
• WHO: The World Medicines Situation. 2004, Geneva: World Health Organization, available at: http:// apps.who.int/medicinedocs/pdf/s6160e/s6160e.pdf 21/08/2017
• Hamrell S, Nordberg O: A Search for Balance: Pharmaceuticals in Sri Lanka. Making National Drug Policies a Development Priority: A Strategy Paper and Six Country Stories. Development dialogue. Edited by: Weerasuriya K. 1995, The Journal of The Dag Hammarskjöld Foundation, 1-available at: http:// apps.who.int/medicinedocs/en/m/abstract/Js19173en/ 22/08/2017
• Vitry A: LJ, Mansfield PR Is Australia's national medicines policy failing? The case of COX-2 inhibitors. Int J Health Serv. 2007, 37 (4): 735-44. 10.2190/HS.37.4.
• Hamrell S, Nordberg O: Australian National Drug Policies: Facilitating or Fragmenting Health. Australian National Drug Policies: Facilitating or Fragmenting Health. Edited by: Murray M. 1995, The Journal of The Dag Hammarskjöld Foundation, available at: http://apps.who.int/medicinedocs/es/m/abstract/ Js19177en/ 23/08/2017
• Department of Health and Ageing, Quality Use Of Medicines: A Decade Of Research, Development and Service Activity 1991 - 2001. 2001, Australian Government, Available at: http://www.health.gov.au/ internet/main/publishing.nsf/Content/nmp-pdf-qumresearch-cnt.htm 23/08/2017
• World Health Organization: Developments in the South African Drug Action Programme. 2001, Available at: http://apps.who.int/medicinedocs/en/d/ Js2230e/2.html

Identyfikatory

DOI

10.7365/JHPOR.2017.1.1